Blog
Featured post
Truveta Data includes linked closed claims for over 200 million patients
By linking complete clinical data with comprehensive claims records, Truveta advances real-world evidence (RWE) generation that can replace, or complement, clinical trials and registries.
Moving from maternal health research to action
The United States has some of the highest rates of adverse maternal health outcomes compared to other high-income countries (Creanga et al., 2015; Gunja et al., 2022; Taylor et...
Monitoring new RSV trends with Truveta
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an...
Truveta Data adds medication dispense data to study medication adherence, addressing nation’s 7th leading cause of death
Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication adherence, and adverse events....
Beyond claims & hospital chargemaster data: Unlocking detailed EHR medical device data
Medical devices play a key role in saving lives and improving patient outcomes on a global scale, yet most information about specific device safety and effectiveness is derived...
Healthcare is complicated…
It is so helpful to have a world view of the industry you participate in, a view that is long term coherent, and toward which everything eventually converges to. Over the course...
A journey into rare disease research
Rare diseases as a category aren’t that rare if you consider they impact 30 million Americans and 400 million people around the world. Not to mention their families, who often...
New research uses Truveta Data to study treatment for hospitalized pregnant patients with COVID-19
Scientists from the Institute for Systems Biology (ISB) have published new research in the JMIR Public Health and Surveillance journal. The work explores the National Institute...
How expert-led AI is powering data-driven insights on less common conditions
Using real-world data to understand a patient’s journey through the healthcare ecosystem can be challenging, particularly for rare or less common diseases. The relevant data are...
Real-time monitoring of prescription trends and demographics of two SGLT2i drugs
We explored the demographic characteristics of patients with type 2 diabetes mellitus, heart failure, and chronic kidney disease who received a prescription for empagliflozin...